Article info

Download PDFPDF

Generation of human T cells directed against an agonist epitope of Brachyury, a transcription factor involved in human tumor cell epithelial to mesenchymal transition (EMT)

Authors

  • Benjamin Boyerinas Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer InstituteNational Institutes of Health Bethesda MD USA PubMed articlesGoogle scholar articles
  • Jo A Tucker Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer InstituteNational Institutes of Health Bethesda MD USA PubMed articlesGoogle scholar articles
  • Diane J Poole Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer InstituteNational Institutes of Health Bethesda MD USA PubMed articlesGoogle scholar articles
  • Caroline Jochéms Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer InstituteNational Institutes of Health Bethesda MD USA PubMed articlesGoogle scholar articles
  • Claudia Palena Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer InstituteNational Institutes of Health Bethesda MD USA PubMed articlesGoogle scholar articles
  • Jeffrey Schlom Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer InstituteNational Institutes of Health Bethesda MD USA PubMed articlesGoogle scholar articles
  • Kwong Y Tsang Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer InstituteNational Institutes of Health Bethesda MD USA PubMed articlesGoogle scholar articles

Citation

Boyerinas B, Tucker JA, Poole DJ, et al
Generation of human T cells directed against an agonist epitope of Brachyury, a transcription factor involved in human tumor cell epithelial to mesenchymal transition (EMT)

Publication history

  • First published November 7, 2013.
Online issue publication 
March 11, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.